• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定纯品和药物制剂中艾托格列净的简单灵敏的反相高效液相色谱法和紫外光谱法

Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations.

作者信息

Itigimatha Nandeesha, Chadchan Kailash S, Yallur Basappa C, Hadagali Manjunatha D

机构信息

Visvesvaraya Technological University, Ramaiah Institute of Technology, Department of Chemistry, Bangalore, India

BLDEA's V.P. Dr. P.G. Halakatti College of Engineering and Technology, Department of Chemistry, Karnataka, India

出版信息

Turk J Pharm Sci. 2022 Apr 29;19(2):213-219. doi: 10.4274/tjps.galenos.2021.55381.

DOI:10.4274/tjps.galenos.2021.55381
PMID:35510349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9083516/
Abstract

Simple, novel and selective reverse phase-high performance liquid chromatography (RP-HPLC) and ultraviolet (UV) spectroscopic methods have been developed and optimized for the determination of remogliflozin etabonate (RMZ) in bulk and dosage forms. In the HPLC method, the principal peak and internal standard peak were eluted separately at different retention times (RT) with the chromatographic conditions such as, mobile phase consisting of 0.02 M ammonium acetate buffer (pH was adjusted to 4.0 by 1.0 M ortho phosphoric acid), acetonitrile and tetrahydrofuran in the ratio 50:45:05, respectively (v/v) and the stationary phase used was C18, 5 μm, 4.6 mm x 250 mm kromasil column. The flow rate was 2.0 mL min, sample injection volume was 10 μL, and the wavelength of detection was fixed at 228 nm. In case UV spectroscopic method, the RMZ was diluted with pure ethanol. The RMZ showed a maximum absorbance at 228 nm. Hence throughout analysis 228 nm was used for the determination of RMZ. The RT of RMZ and internal standard, atorvastatin (ATST) were 6.2 min and 7.0 min, respectively. The resolution between the peaks was found to be more than 2.0. The total run time was fixed at 10 min. The linearity range for RP-HPLC method was found to be 10 μg mL to 50 μg mL, at a fixed concentration of ATST. The linearity range for the UV spectroscopic method was found to be in the range of 100 to 250 μg mL. Regression coefficients (R2) were found above 0.999 for both of the techniques. The limit of detection and quantification for RMZ were found to be 1.0 μg mL-1 and 3.5 μg mL respectively, in RP-HPLC method and 10.0 μg mL and 40 μg mL, respectively, in UV spectroscopic method. The developed methods were found to be simple, accurate, reproducible, and precise. The RMZ can be analyzed in dual techniques, ., chromatographic and UV spectroscopic methods for its routine analysis.

摘要

已开发并优化了简单、新颖且具选择性的反相高效液相色谱法(RP-HPLC)和紫外(UV)光谱法,用于测定原料药及制剂中的瑞格列净乙酯(RMZ)。在HPLC法中,主峰和内标峰在不同保留时间(RT)分别洗脱,色谱条件如下:流动相由0.02 M醋酸铵缓冲液(用1.0 M正磷酸将pH调至4.0)、乙腈和四氢呋喃按50:45:05的比例(v/v)组成,所用固定相为C18、5μm、4.6 mm×250 mm的科马西色谱柱。流速为2.0 mL/min,进样体积为10μL,检测波长固定在228 nm。在UV光谱法中,RMZ用无水乙醇稀释。RMZ在228 nm处有最大吸收。因此,在整个分析过程中,228 nm用于RMZ的测定。RMZ和内标阿托伐他汀(ATST)的保留时间分别为6.2 min和7.0 min。发现峰之间的分离度大于2.0。总运行时间固定为10 min。在ATST固定浓度下,RP-HPLC法的线性范围为10μg/mL至50μg/mL。UV光谱法的线性范围为100至250μg/mL。两种技术的回归系数(R2)均高于0.999。在RP-HPLC法中,RMZ的检测限和定量限分别为1.0μg/mL-1和3.5μg/mL,在UV光谱法中分别为10.0μg/mL和40μg/mL。所开发的方法简单、准确、可重现且精密。RMZ可通过两种技术进行分析,即色谱法和UV光谱法,用于其常规分析。

相似文献

1
Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations.用于测定纯品和药物制剂中艾托格列净的简单灵敏的反相高效液相色谱法和紫外光谱法
Turk J Pharm Sci. 2022 Apr 29;19(2):213-219. doi: 10.4274/tjps.galenos.2021.55381.
2
New Analytical Methods for the Determination of New Anti-Viral Drug Favipiravir: A Potential Therapeutic Drug Against Covid-19 Virus, in Bulk and Dosage Forms.新型抗病毒药物法匹拉韦的测定新分析方法:一种针对新冠病毒的潜在治疗药物,用于原料药和剂型
Pharm Chem J. 2023;56(10):1419-1425. doi: 10.1007/s11094-023-02807-2. Epub 2023 Jan 12.
3
Development of a Simple RP-HPLC-UV Method for Determination of Azithromycin in Bulk and Pharmaceutical Dosage forms as an Alternative to the USP Method.开发一种简单的反相高效液相色谱-紫外法测定原料药和药物制剂中的阿奇霉素,作为美国药典方法的替代方法。
Iran J Pharm Res. 2013 Winter;12(Suppl):57-63.
4
Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms.反相高效液相色谱法同时测定原料药和片剂剂型中阿巴卡韦和拉米夫定的分析方法开发与验证
Pharmacognosy Res. 2018 Jan-Mar;10(1):92-97. doi: 10.4103/pr.pr_96_17.
5
Development and Validation of RP-HPLC Method for Simultaneous Estimation of Cefpodoxime Proxetil and Dicloxacillin Sodium in Tablets.反相高效液相色谱法同时测定片剂中头孢泊肟酯和双氯西林钠的方法开发与验证
Indian J Pharm Sci. 2013 Jan;75(1):31-5. doi: 10.4103/0250-474X.113538.
6
Application of Factorial and Doehlert Designs for the Optimization of the Simultaneous Separation and Determination of Antimigraine Drugs in Pharmaceutical Formulations by RP-HPLC-UV.析因设计和Doehlert设计在通过反相高效液相色谱-紫外法同时分离和测定药物制剂中抗偏头痛药物的优化中的应用。
Int J Anal Chem. 2019 Aug 15;2019:9685750. doi: 10.1155/2019/9685750. eCollection 2019.
7
Stability-indicating green HPLC method for fixed-dose tablets containing remogliflozin etabonate and teneligliptin: an AQbD approach.含瑞格列净恩格列净酯和替格列汀的固定剂量片剂的稳定性指示性绿色 HPLC 方法:一种基于 AQbD 的方法。
Drug Dev Ind Pharm. 2024 Aug;50(8):750-762. doi: 10.1080/03639045.2024.2400199. Epub 2024 Sep 11.
8
RP-HPLC-UV method development and validation for simultaneous determination of terbutaline sulphate, ambroxol HCl and guaifenesin in pure and dosage forms.反相高效液相色谱-紫外法同时测定硫酸特布他林、盐酸氨溴索和愈创甘油醚原料药及制剂的方法开发与验证
Ann Pharm Fr. 2019 Jul;77(4):295-301. doi: 10.1016/j.pharma.2019.02.004. Epub 2019 Apr 23.
9
Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations.反相高效液相色谱法对药物制剂中阿托伐他汀钙和苯磺酸氨氯地平的稳定性指示测定
Indian J Pharm Sci. 2008 Nov;70(6):754-60. doi: 10.4103/0250-474X.49117.
10
Simultaneous determination of paracetamol and lornoxicam by RP-HPLC in bulk and tablet formulation.采用反相高效液相色谱法同时测定原料药及片剂中对乙酰氨基酚和氯诺昔康的含量。
Pharm Methods. 2011 Jan;2(1):61-6. doi: 10.4103/2229-4708.81084.

引用本文的文献

1
Quality by Design Tool Assessed Ultraperformance Liquid Chromatography Method for the Analysis of Remogliflozin and Teneligliptin in Oral Dosage Form.质量源于设计工具评估的超高效液相色谱法用于分析口服剂型中的瑞格列净和替格列汀
ACS Omega. 2024 Mar 7;9(11):12553-12563. doi: 10.1021/acsomega.3c04589. eCollection 2024 Mar 19.

本文引用的文献

1
A Novel Analytical Method for the Simultaneous Estimation of Remogliflozin and Metformin Hydrochloride by UPLC/PDA in Bulk and Formulation Application to the Estimation of Product Traces.一种采用超高效液相色谱/光电二极管阵列检测器同时测定散装和制剂中瑞格列净和盐酸二甲双胍的新分析方法及其在产品痕量测定中的应用
Turk J Pharm Sci. 2021 Jun 18;18(3):296-305. doi: 10.4274/tjps.galenos.2020.39699.
2
Development and Validation of Green UV Derivative Spectrophotometric Methods for Simultaneous Determination Metformin and Remogliflozin from Formulation: Evaluation of Greenness.开发和验证绿色紫外衍生分光光度法同时测定配方中二甲双胍和瑞格列净的含量:绿色度评估。
Int J Environ Res Public Health. 2021 Jan 8;18(2):448. doi: 10.3390/ijerph18020448.
3
Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation.用于同时测定恩格列净和二甲双胍的简单分光光度法和化学计量学方法的开发与验证:应用于最近批准的药物制剂
Spectrochim Acta A Mol Biomol Spectrosc. 2016 Nov 5;168:118-122. doi: 10.1016/j.saa.2016.06.010. Epub 2016 Jun 6.
4
Development and validation of the liquid chromatographic method for simultaneous estimation of metformin, pioglitazone, and glimepiride in pharmaceutical dosage forms.同时测定药物制剂中二甲双胍、吡格列酮和格列美脲的液相色谱法的建立与验证
Pharm Methods. 2012 Jan;3(1):9-13. doi: 10.4103/2229-4708.97707.
5
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.瑞格列净依托酸酯,一种新型 SGLT2 抑制剂,与二甲双胍在 2 型糖尿病患者中联合使用的安全性、药代动力学和药效学。
BMC Pharmacol Toxicol. 2013 Apr 30;14:25. doi: 10.1186/2050-6511-14-25.